• 1
    Dohan D, Schrag D. Using navigators to improve care of underserved patients: current practices and approaches. Cancer. 2005; 104: 848-55.
  • 2
    Smedley B, Stith A, Nelson A. Unequal treatment: confronting racial and ethnic disparities in health care. Washington, DC: National Academies Press; 2003.
  • 3
    Blackman DJ, Masi CM. Racial and ethnic disparities in breast cancer mortality: are we doing enough to address the root causes? J Clin Oncol. 2006; 24: 2170-2178.
  • 4
    Bruner DW, Jones M, Buchanan D, Russo J. Reducing cancer disparities for minorities: a multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy. J Clin Oncol. 2006; 24: 2209-2215.
  • 5
    Doescher MP, Saver BG, Franks P, Fiscella K. Racial and ethnic disparities in perceptions of physician style and trust. Arch Fam Med. 2000; 9: 1156-1163.
  • 6
    Freeman HP. Poverty, culture, and social injustice: determinants of cancer disparities. CA Cancer J Clin. 2004; 54: 72-77.
  • 7
    Geiger H. Racial and ethnic disparities in diagnosis and treatment: a review of the evidence and consideration of causes. In: SmedleyB, SmithA, NelsonA, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press; 2003: 415-454.
  • 8
    Glanz K, Croyle RT, Chollette VY, Pinn VW. Cancer-related health disparities in women. Am J Public Health. 2003; 93: 292-298.
  • 9
    Guadagnolo BA, Cina K, Helbig P, et al. Assessing cancer stage and screening disparities among Native American cancer patients. Public Health Rep. 2009; 124: 79-89.
  • 10
    Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002; 94: 334-357.
  • 11
    Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004; 54: 78-93.
  • 12
    America's Affordable Health Choices Act of 2009, HR 3200, 111th Cong (2009-2010).
  • 13
    Guadagnolo BA, Cina K, Helbig P, et al. Medical mistrust and less satisfaction with health care among Native Americans presenting for cancer treatment. J Health Care Poor Underserved. 2009; 20: 210-226.
  • 14
    Freeman HP, Muth BJ, Kerner JF. Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract. 1995; 3: 19-30.
  • 15
    Wells KJ, Battaglia TA, Dudley DJ, et al. Patient navigation: state of the art or is it science? Cancer. 2008; 113: 1999-2010.
  • 16
    Freund KM, Battaglia TA, Calhoun E, et al. National Cancer Institute Patient Navigation Research Program: methods, protocol, and measures. Cancer. 2008; 113: 3391-3399.
  • 17
    Oluwole SF, Ali AO, Adu A, et al. Impact of a cancer screening program on breast cancer stage at diagnosis in a medically underserved urban community. J Am Coll Surg. 2003; 196: 180-188.
  • 18
    Gabram SG, Lund MJ, Gardner J, et al. Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population. Cancer. 2008; 113: 602-607.
  • 19
    Battaglia TA, Roloff K, Posner MA, Freund KM. Improving follow-up to abnormal breast cancer screening in an urban population. A patient navigation intervention. Cancer. 2007; 109( 2 Suppl): 359-367.
  • 20
    Ferrante JM, Chen PH, Kim S. The effect of patient navigation on time to diagnosis, anxiety, and satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. J Urban Health. 2008; 85: 114-124.
  • 21
    Department of Health and Human Services Centers for Disease Control and Prevention. National Breast and Cervical Cancer Early Detection Program publications: Overview of the program management chapter of the NBCCEDP policies and procedures manual. Available at: Accessed May 24, 2010.
  • 22
    Department of Health and Human Services Centers for Disease Control and Prevention. National Breast and Cervical Cancer Early Detection Program: screening program data. Available at: Accessed May 24, 2010.
  • 23
    Psooy BJ, Schreuer D, Borgaonkar J, Caines JS. Patient navigation: improving timeliness in the diagnosis of breast abnormalities. Can Assoc Radiol J. 2004; 55: 145-150.
  • 24
    Schwaderer KA, Proctor JW, Martz EF, Slack RJ, Ricci E. Evaluation of patient navigation in a community radiation oncology center involved in disparities studies: a time-to-completion-of-treatment study. J Oncol Pract. 2008; 4: 220-224.
  • 25
    Fillion L, de Serres M, Cook S, Goupil RL, Bairati I, Doll R. Professional patient navigation in head and neck cancer. Semin Oncol Nurs. 2009; 25: 212-221.
  • 26
    Ell K, Vourlekis B, Xie B, et al. Cancer treatment adherence among low-income women with breast or gynecologic cancer: a randomized controlled trial of patient navigation. Cancer. 2009; 115: 4606-4615.
  • 27
    Petereit D, Molloy K, Reiner M, et al. Establishing a patient navigator program to reduce cancer disparities in the American Indian communities of western South Dakota: initial observations and results. Cancer Control. 2008; 15: 254-259.
  • 28
    Lin CJ, Schwaderer KA, Morgenlander KH, et al. Factors associated with patient navigators' time spent on reducing barriers to cancer treatment. J Natl Med Assoc. 2008; 100: 1290-1297.
  • 29
    Raich P, Valverde P, Thorland W, et al. The relationship between patient co-morbidities and perceived barriers in a group of underserved patients with cancer or at risk for cancer. Poster presented at: 30th Annual Meeting of the Society of Behavioral Medicine; April 22-25, 2009; Montreal, Canada.
  • 30
    Sateren WB, Trimble EL, Abrams J, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol. 2002; 20: 2109-2117.
  • 31
    Maurer LH, Davis T, Hammond S, Smith E, West P, Doolittle M. Clinical trials in a rural population: professional education aspects. J Cancer Educ. 2001; 16: 89-92.
  • 32
    Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004; 291: 2720-2726.
  • 33
    Swanson GM, Bailar JC 3rd. Selection and description of cancer clinical trials participants—science or happenstance? Cancer. 2002; 95: 950-959.
  • 34
    Baquet CR, Commiskey P, Daniel Mullins C, Mishra SI. Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictors. Cancer Detect Prev. 2006; 30: 24-33.
  • 35
    Stewart JH, Bertoni AG, Staten JL, Levine EA, Gross CP. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol. 2007; 14: 3328-3334.
  • 36
    Gross CP, Filardo G, Mayne ST, Krumholz HM. The impact of socioeconomic status and race on trial participation for older women with breast cancer. Cancer. 2005; 103: 483-491.
  • 37
    Petereit DG, Rogers D, Govern F, et al. Increasing access to clinical cancer trials and emerging technologies for minority populations: the Native American Project. J Clin Oncol. 2004; 22: 4452-4455.
  • 38
    Espey DK, Wu XC, Swan J, et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer. 2007; 110: 2119-2152.
  • 39
    Guadagnolo BA, Petereit DG, Helbig P, et al. Involving American Indians and medically underserved rural populations in cancer clinical trials. Clin Trials. 2009; 6: 610-617.
  • 40
    Rochon PA, Mashari A, Cohen A, et al. The inclusion of minority groups in clinical trials: problems of under representation and under reporting of data. Account Res. 2004; 11: 215-223.
  • 41
    Schneider EC, Malin JL, Kahn KL, Emanuel EJ, Epstein AM. Developing a system to assess the quality of cancer care: ASCO's national initiative on cancer care quality. J Clin Oncol. 2004; 22: 2985-2991.
  • 42
    Malin JL, Schneider EC, Epstein AM, Adams J, Emanuel EJ, Kahn KL. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? J Clin Oncol. 2006; 24: 626-634.
  • 43
    Prosnitz RG, Patwardhan MB, Samsa GP, et al. Quality measures for the use of adjuvant chemotherapy and radiation therapy in patients with colorectal cancer: a systematic review. Cancer. 2006; 107: 2352-2360.
  • 44
    Patwardhan MB, Samsa GP, McCrory DC, et al. Cancer care quality measures: diagnosis and treatment of colorectal cancer. Evid Rep Technol Assess (Full Rep). 2006; 138: 1-116.
  • 45
    Smith GL, Shih YC, Xu Y, et al. Racial disparities in the use of radiotherapy after breast-conserving surgery: a national Medicare study. Cancer. 2010; 116: 734-741.
  • 46
    Bhargava A, Du XL. Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node-positive, operable breast cancer. Cancer. 2009; 115: 2999-3008.
  • 47
    Morris AM, Billingsley KG, Hayanga AJ, Matthews B, Baldwin LM, Birkmeyer JD. Residual treatment disparities after oncology referral for rectal cancer. J Natl Cancer Inst. 2008; 100: 738-744.
  • 48
    Yoon J, Malin JL, Tisnado DM, et al. Symptom management after breast cancer treatment: is it influenced by patient characteristics? Breast Cancer Res Treat. 2008; 108: 69-77.
  • 49
    Petereit DG, Sarkaria JN, Chappell R, et al. The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys. 1995; 32: 1301-1307.
  • 50
    McCloskey SA, Jaggernauth W, Rigual NR, et al. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck. Am J Clin Oncol. 2009; 32: 587-591.
  • 51
    Rades D, Stoehr M, Kazic N, et al. Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy. Int J Radiat Oncol Biol Phys. 2008; 70: 1108-1114.
  • 52
    Rose C, Stovall E, Ganz PA, Desch C, Hewitt M. Cancer Quality Alliance: blueprint for a better cancer care system. CA Cancer J Clin. 2008; 58: 266-292.
  • 53
    American Academy of Family Physicians. Joint principles of a patient-centered medical home released by organizations representing more than 300,000 physicians. Available at: Accessed June 3, 2010.